Physician profile
Robert J Paulino
NPI 1528221165
$950.30
in general payments reported to CMS, 2019-2025
16 companies · $440 in 2025
The $440 reported for 2025 was more than what 90% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $19.32 · 2024: $366 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $152.23 | 2019-2025 | Airsupra |
| Penumbra, INC. | $133.25 | 2024 | Indigo System |
| Pfizer INC. | $99.82 | 2024-2025 | |
| Novo Nordisk INC | $96.77 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $89.95 | 2024-2025 | |
| Glaxosmithkline, LLC. | $63.22 | 2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $61.84 | 2024-2025 | Mounjaro, Zepbound, Kisunla |
| Exact Sciences Corporation | $55.46 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.53 | 2025 | Jardiance |
| Amgen INC. | $27.29 | 2025 | Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $25.30 | 2025 | |
| Corcept Therapeutics | $24.84 | 2024 | Korlym |
| Otsuka America Pharmaceutical, INC. | $19.99 | 2025 | Rexulti |
| Convatec INC. | $19.32 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.87 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.62 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Paulino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.